Martin Stockler

26PUBLICATIONS

174CO-AUTHORS

Predictive and prognostic markersDevelopment cooperationPharmacogenomicsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 26, 2026

AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Jun 08, 2026

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

|Jun 08, 2026

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

|Apr 28, 2026

<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Apr 15, 2026

Predictive value of early PSMA upregulation for the response to enzalutamide ± <sup>177</sup>Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.

|Feb 06, 2026

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

Pageof 5

Frequent Collaborators

10 joint publications

Ian D Davis

Anthony M Joshua

Rachael L Morton

Louise Emmett

Shahneen Sandhu

Andrew Martin

Christopher J Sweeney

3 joint publications

Ann Livingstone

3 joint publications

Alexander M Menzies

3 joint publications

Rebecca Mercieca-Bebber

Frequent Collaborators

10 joint publications

Ian D Davis

7 joint publications

Anthony M Joshua

4 joint publications

Rachael L Morton

4 joint publications

Louise Emmett